Resultados de la búsqueda 1 – 20 de 35
Appendix C: CDC Pediatric HIV CD4 Cell Count/Percentage and HIV-Related Diseases Categorization
Guidelines Panel Members
Appendix A: Pediatric Antiretroviral Drug Information
Appendix B: Acronyms
Management of Medication Toxicity or Intolerance
Management of Children Receiving Antiretroviral Therapy
Introduction
Special Considerations for Antiretroviral Therapy Use in Adolescents with HIV
Antiretroviral Management of Newborns with Perinatal HIV Exposure or HIV Infection
What to Start
Financial Disclosure
When to Initiate Therapy in Antiretroviral-Naive Children
Appendix D: Supplemental Information
Adherence to Antiretroviral Therapy in Children and Adolescents with HIV
Diagnosis of HIV Infection in Infants and Children
What's New in the Guidelines
Maternal HIV Testing and Identification of Perinatal HIV Exposure
Clinical and Laboratory Monitoring of Pediatric HIV Infection
Pre-exposure Prophylaxis (PrEP) to Prevent HIV During Periconception, Antepartum, and Postpartum Periods
Special Populations